PROX1 and cholangiocarcinoma: This study expands our understanding of the transcriptomic behavior of RNF135, EFBN2, RNF125, ABLIM1, HOXC4, OSMR and PROX1-AS1 in HCC, CCA, CRLM, PCLM and NATs.